Activation and pathogenic manipulation of the sensors of the innate immune system

Microbes and Infection

Volumn 19, Issue 4-5, 2017, Pages 229-237

  Odendall, Charlotte ^a   Kagan, Jonathan C ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Immune evasion; Infection; Inflammasome; Innate immunity; Myddosome; Toll like receptors

Indexed keywords

DNA; INFLAMMASOME; PATTERN RECOGNITION RECEPTOR; RIG I LIKE RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; VIRUS RNA;

CELL MEMBRANE; CELLULAR DISTRIBUTION; CYTOSOL; ENDOSOME; HUMAN; IMMUNE EVASION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MITOCHONDRION; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SHORT SURVEY; ADAPTIVE IMMUNITY; IMMUNOLOGY; SIGNAL TRANSDUCTION;

ADAPTIVE IMMUNITY; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION;

EID: 85014405788     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2017.01.003     Document Type: Short Survey

References (104)

1. [1] Janeway, C.A. J, Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symposia Quantitative Biol 54 (1989), 1–13.
2. [2] Gay, N.J., Keith, F.J., Drosophila toll and IL-1 receptor. Nature 351 (1991), 355–356.
3. [3] Anderson, K.V., Jürgens, G., Nüsslein-Volhard, C., Establishment of dorsal-ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product. Cell 42 (1985), 779–789.
4. [4] Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.M., Hoffmann, J.A., The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86 (1996), 973–983.
5. [5] Medzhitov, R., Preston-Hurlburt, P., Janeway, C.A., A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997), 394–397.
6. [6] Kagan, J.C., Magupalli, V.G., Wu, H., SMOCs: supramolecular organizing centres that control innate immunity. Nat Rev Immunol 14 (2014), 821–826.
7. [7] Oliveira-Nascimento, L., Massari, P., Wetzler, L.M., The role of TLR2 in infection and immunity. Front Immunol, 3, 2012, 79.
8. [8] Oosting, M., Cheng, S.-C., Bolscher, J.M., Vestering-Stenger, R., Plantinga, T.S., Verschueren, I.C., et al. Human TLR10 is an anti-inflammatory pattern-recognition receptor. Proc Natl Acad Sci U. S. A 111 (2014), E4478–E4484.
9. [9] Koblansky, A.A., Jankovic, D., Oh, H., Hieny, S., Sungnak, W., Mathur, R., et al. Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii. Immunity 38 (2013), 119–130.
10. [10] Oldenburg, M., Krüger, A., Ferstl, R., Kaufmann, A., Nees, G., Sigmund, A., et al. TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science 337 (2012), 1111–1115.
11. [11] Kagan, J.C., Defining the subcellular sites of innate immune signal transduction. Trends Immunol 33 (2012), 442–448.
12. [12] Horng, T., Barton, G.M., Flavell, R.A., Medzhitov, R., The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420 (2002), 329–333.
13. [13] Kagan, J.C., Medzhitov, R., Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125 (2006), 943–955.
14. [14] Kagan, J.C., Su, T., Horng, T., Chow, A., Akira, S., Medzhitov, R., TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 9 (2008), 361–368.
15. [15] Bonham, K.S., Orzalli, M.H., Hayashi, K., Wolf, A.I., Glanemann, C., Weninger, W., et al. A promiscuous lipid-binding protein diversifies the subcellular sites of toll-like receptor signal transduction. Cell 156 (2014), 705–716.
16. [16] Rowe, D.C., McGettrick, A.F., Latz, E., Monks, B.G., Gay, N.J., Yamamoto, M., et al. The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. Proc Natl Acad Sci U. S. A 103 (2006), 6299–6304.
17. [17] Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T., Seya, T., TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 4 (2003), 161–167.
18. [18] Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 5633 (2003), 640–643.
19. [19] Yamamoto, M., Sato, S., Hemmi, H., Uematsu, S., Hoshino, K., Kaisho, T., et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 4 (2003), 1144–1150.
20. [20] Fitzgerald, K.A., Palsson-McDermott, E.M., Bowie, A.G., Jefferies, C.A., Mansell, A.S., Brady, G., et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413 (2001), 78–83.
21. [21] Medzhitov, R., Preston-Hurlburt, P., Kopp, E., Stadlen, A., Chen, C., Ghosh, S., et al. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 2 (1998), 253–258.
22. [22] Cirl, C., Wieser, A., Yadav, M., Duerr, S., Schubert, S., Fischer, H., et al. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain|[ndash]|containing proteins. Nat Med 14 (2008), 399–406.
23. [23] Sengupta, D., Koblansky, A., Gaines, J., Brown, T., West, A.P., Zhang, D., et al. Subversion of innate immune responses by Brucella through the targeted degradation of the TLR signaling adapter, MAL. J Immunol 184 (2010), 956–964.
24. [24] van Lint, A.L., Murawski, M.R., Goodbody, R.E., Severa, M., Fitzgerald, K.A., Finberg, R.W., et al. Herpes simplex virus immediate-early ICP0 protein inhibits Toll-like receptor 2-dependent inflammatory responses and NF-kappaB signaling. J Virol 84 (2010), 10802–10811.
25. [25] Stack, J., Haga, I.R., Schröder, M., Bartlett, N.W., Maloney, G., Reading, P.C., et al. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med 201 (2005), 1007–1018.
26. [26] Terebiznik, M.R., Vieira, O.V., Marcus, S.L., Slade, A., Yip, C.M., Trimble, W.S., et al. Elimination of host cell PtdIns(4,5)P2 by bacterial SigD promotes membrane fission during invasion by Salmonella. Nat Cell Biol 4 (2002), 766–773.
27. [27] Zhou, D., Chen, L.M., Hernandez, L., Shears, S.B., Galan, J.E., A Salmonella inositol polyphosphatase acts in conjunction with other bacterial effectors to promote host cell actin cytoskeleton rearrangements and bacterial internalization. Mol Microbiol 39 (2001), 248–260.
28. [28] Li, K., Foy, E., Ferreon, J.C., Nakamura, M., Ferreon, A.C.M., Ikeda, M., et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U. S. A 102 (2005), 2992–2997.
29. [29] Xiang, Z., Li, L., Lei, X., Zhou, H., Zhou, Z., He, B., et al. Enterovirus 68 3C protease cleaves TRIF to attenuate antiviral responses mediated by Toll-like receptor 3. J Virol 88 (2014), 6650–6659.
30. [30] Mukherjee, A., Morosky, S.A., Delorme-Axford, E., Dybdahl-Sissoko, N., Oberste, M.S., Wang, T., et al. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog, 7, 2011, e1001311.
31. [31] Zanoni, I., Ostuni, R., Marek, L.R., Barresi, S., Barbalat, R., Barton, G.M., et al. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 147 (2011), 868–880.
32. [32] Tan, Y., Zanoni, I., Cullen, T.W., Goodman, A.L., Kagan, J.C., Mechanisms of toll-like receptor 4 endocytosis reveal a common immune-evasion strategy used by pathogenic and commensal bacteria. Immunity 43 (2015), 909–922.
33. [33] Kim, Y.-M., Brinkmann, M.M., Paquet, M.-E., Ploegh, H.L., UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 452 (2008), 234–238.
34. [34] Lee, B.L., Moon, J.E., Shu, J.H., Yuan, L., Newman, Z.R., Schekman, R., et al. UNC93B1 mediates differential trafficking of endosomal TLRs. Elife, 2, 2013, e00291.
35. [35] Lee, C.C., Avalos, A.M., Ploegh, H.L., Accessory molecules for Toll-like receptors and their function. Nat Rev Immunol 12 (2012), 168–179.
36. [36] Tabeta, K., Hoebe, K., Janssen, E.M., Du, X., Georgel, P., Crozat, K., et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol 7 (2006), 156–164.
37. [37] Casrouge, A., Zhang, S.-Y., Eidenschenk, C., Jouanguy, E., Puel, A., Yang, K., et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314 (2006), 308–312.
38. [38] Harris, K.G., Coyne, C.B., Unc93b induces apoptotic cell death and is cleaved by host and enteroviral proteases. PLoS One, 10, 2015, e0141383.
39. [39] Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5 (2004), 730–737.
40. [40] Kang, D.-C., Gopalkrishnan, R.V., Wu, Q., Jankowsky, E., Pyle, A.M., Fisher, P.B., mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc Natl Acad Sci U. S. A 99 (2002), 637–642.
41. [41] Andrejeva, J., Childs, K.S., Young, D.F., Carlos, T.S., Stock, N., Goodbourn, S., et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci U. S. A 101 (2004), 17264–17269.
42. [42] Satoh, T., Kato, H., Kumagai, Y., Yoneyama, M., Sato, S., Matsushita, K., et al. LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci U. S. A 107 (2010), 1512–1517.
43. [43] Malur, M., Gale, M., Krug, R.M., LGP2 downregulates interferon production during infection with seasonal human influenza a viruses that activate interferon regulatory factor 3. J Virol 86 (2012), 10733–10738.
44. [44] Rothenfusser, S., Goutagny, N., DiPerna, G., Gong, M., Monks, B.G., Schoenemeyer, A., et al. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible Gene-I. J Immunol 175 (2005), 5260–5268.
45. [45] Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441 (2006), 101–105.
46. [46] Hornung, V., Ellegast, J., Kim, S., Brzózka, K., Jung, A., Kato, H., et al. 5'-Triphosphate RNA is the ligand for RIG-I. Science 314 (2006), 994–997.
47. [47] Kato, H., Takeuchi, O., Mikamo-Satoh, E., Hirai, R., Kawai, T., Matsushita, K., et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 205 (2008), 1601–1610.
48. [48] Masatani, T., Ito, N., Shimizu, K., Ito, Y., Nakagawa, K., Sawaki, Y., et al. Rabies virus nucleoprotein functions to evade activation of the RIG-I-mediated antiviral response. J Virol 84 (2010), 4002–4012.
49. [49] Manokaran, G., Finol, E., Wang, C., Gunaratne, J., Bahl, J., Ong, E.Z., et al. Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness. Science 350 (2015), 217–221.
50. [50] Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 (2005), 1167–1172.
51. [51] Xu, L.-G., Wang, Y.-Y., Han, K.-J., Li, L.-Y., Zhai, Z., Shu, H.-B., VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19 (2005), 727–740.
52. [52] Seth, R.B., Sun, L., Ea, C.-K., Chen, Z.J., Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122 (2005), 669–682.
53. [53] Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6 (2005), 981–988.
54. [54] Dixit, E., Boulant, S., Zhang, Y., Lee, A.S.Y., Odendall, C., Shum, B., et al. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141 (2010), 668–681.
55. [55] Horner, S.M., Liu, H.M., Park, H.S., Briley, J., Gale, M., Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc Natl Acad Sci U. S. A 108 (2011), 14590–14595.
56. [56] Liu, H.M., Loo, Y.-M., Horner, S.M., Zornetzer, G.A., Katze, M.G., Gale, M., The mitochondrial targeting chaperone 14-3-3ε regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity. Cell Host Microbe 11 (2012), 528–537.
57. [57] Chan, Y.K., Gack, M.U., A phosphomimetic-based mechanism of dengue virus to antagonize innate immunity. Nat Immunol 17 (2016), 523–530.
58. [58] Kumar, H., Kawai, T., Kato, H., Sato, S., Takahashi, K., Coban, C., et al. Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 203 (2006), 1795–1803.
59. [59] Odendall, C., Dixit, E., Stavru, F., Bierne, H., Franz, K.M., Durbin, A.F., et al. Diverse intracellular pathogens activate type III interferon expression from peroxisomes. Nat Immunol 15 (2014), 717–726.
60. [60] Sun, Q., Sun, L., Liu, H.-H., Chen, X., Seth, R.B., Forman, J., et al. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24 (2006), 633–642.
61. [61] Li, X., Sun, L., Seth, R., Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U. S. A 49 (2005), 17717–17722.
62. [62] Abdullah, Z., Schlee, M., Roth, S., Mraheil, M.A., Barchet, W., Böttcher, J., et al. RIG-I detects infection with live Listeria by sensing secreted bacterial nucleic acids. Embo J 31 (2012), 4153–4164.
63. [63] Chiu, Y.-H., MacMillan, J.B., Chen, Z.J., RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138 (2009), 576–591.
64. [64] Monroe, K.M., McWhirter, S.M., Vance, R.E., Identification of host cytosolic sensors and bacterial factors regulating the type I interferon response to Legionella pneumophila. PLoS Pathog, 5, 2009, e1000665.
65. [65] Creasey, E.A., Isberg, R.R., The protein SdhA maintains the integrity of the Legionella-containing vacuole. Proc Natl Acad Sci U. S. A 109 (2012), 3481–3486.
66. [66] Koshiba, T., Yasukawa, K., Yanagi, Y., Kawabata, S.-I., Mitochondrial membrane potential is required for MAVS-mediated antiviral signaling. Sci Signal, 4, 2011, ra7.
67. [67] Stavru, F., Cossart, P., Listeria infection modulates mitochondrial dynamics. Commun Integr Biol 4 (2011), 364–366.
68. [68] Anand, S.K., Tikoo, S.K., Viruses as modulators of mitochondrial functions. Adv Virol 2013 (2013), 1–17.
69. [69] Chatel-Chaix, L., Cortese, M., Romero-Brey, I., Bender, S., Neufeldt, C.J., Fischl, W., et al. Dengue virus perturbs mitochondrial morphodynamics to dampen innate immune responses. Cell Host Microbe 20 (2016), 342–356.
70. [70] Odendall, C., Kagan, J.C., The unique regulation and functions of type III interferons in antiviral immunity. Curr Opin Virol 12 (2015), 47–52, 10.1016/j.coviro.2015.02.003.
71. [71] Odendall, C., Kagan, J.C., Peroxisomes and the antiviral responses of Mammalian cells. Subcell Biochem 69 (2013), 67–75.
72. [72] You, J., Hou, S., Malik-Soni, N., Xu, Z., Kumar, A., Rachubinski, R.A., et al. Flavivirus infection impairs peroxisome biogenesis and early anti-viral signaling. J Virol. 89:24 (2015 Dec), 12349–12361.
73. [73] Dempsey, A., Bowie, A.G., Innate immune recognition of DNA: a recent history. Virology 479–480 (2015), 146–152.
74. [74] Wu, J., Sun, L., Chen, X., Du, F., Shi, H., Chen, C., et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339 (2012), 826–830.
75. [75] Sun, L., Wu, J., Du, F., Chen, X., Chen, Z.J., Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339 (2012), 786–791.
76. [76] Unterholzner, L., Keating, S.E., Baran, M., Horan, K.A., Jensen, S.B., Sharma, S., et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 11 (2010), 997–1004.
77. [77] Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D.R., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458 (2009), 514–518.
78. [78] Ishikawa, H., Barber, G.N., STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455 (2008), 674–678.
79. [79] Ishikawa, H., Barber, G.N., The STING pathway and regulation of innate immune signaling in response to DNA pathogens. Cell Mol Life Sci 68 (2010), 1157–1165.
80. [80] Zhong, B., Yang, Y., Li, S., Wang, Y.-Y., Li, Y., Diao, F., et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29 (2008), 538–550.
81. [81] Burdette, D.L., Monroe, K.M., Sotelo-Troha, K., Iwig, J.S., Eckert, B., Hyodo, M., et al. STING is a direct innate immune sensor of cyclic di-GMP. Nature 478 (2011), 1–5.
82. [82] Abe, T., Barber, G.N., Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-κB activation through TBK1. J Virol 88 (2014), 5328–5341.
83. [83] Chan, Y.K., Gack, M.U., Viral evasion of intracellular DNA and RNA sensing. Nat Rev Microbiol 14 (2016), 360–373.
84. [84] Dell'Oste, V., Gatti, D., Gugliesi, F., De Andrea, M., Bawadekar, M., Cigno Lo, I., et al. Innate nuclear sensor IFI16 translocates into the cytoplasm during the early stage of in vitro human cytomegalovirus infection and is entrapped in the egressing virions during the late stage. J Virol 88 (2014), 6970–6982.
85. [85] Barber, G.N., STING-dependent cytosolic DNA sensing pathways. Trends Immunol 35 (2014), 88–93.
86. [86] Burnaevskiy, N., Fox, T.G., Plymire, D.A., Ertelt, J.M., Weigele, B.A., Selyunin, A.S., et al. Proteolytic elimination of N-myristoyl modifications by the Shigella virulence factor IpaJ. Nature 496 (2013), 106–109.
87. [87] Dong, N., Zhu, Y., Lu, Q., Hu, L., Zheng, Y., Shao, F., Structurally distinct bacterial TBC-like GAPs link Arf GTPase to Rab1 inactivation to counteract host defenses. Cell 150 (2012), 1029–1041.
88. [88] Dobbs, N., Burnaevskiy, N., Chen, D., Gonugunta, V.K., Alto, N.M., Yan, N., STING activation by translocation from the ER is associated with infection and autoinflammatory disease. Cell Host Microbe 18 (2015), 157–168.
89. [89] Nakamura, N., Lill, J.R., Phung, Q., Jiang, Z., Bakalarski, C., de Mazière, A., et al. Endosomes are specialized platforms for bacterial sensing and NOD2 signalling. Nature 509 (2014), 240–244.
90. [90] Irving, A.T., Mimuro, H., Kufer, T.A., Lo, C., Wheeler, R., Turner, L.J., et al. The immune receptor NOD1 and kinase RIP2 interact with bacterial peptidoglycan on early endosomes to promote autophagy and inflammatory signaling. Cell Host Microbe 15 (2014), 623–635.
91. [91] Broz, P., Dixit, V.M., Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol 16 (2016), 407–420.
92. [92] Kayagaki, N., Wong, M.T., Stowe, I.B., Ramani, S.R., Gonzalez, L.C., Akashi-Takamura, S., et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341 (2013), 1246–1249.
93. [93] Kayagaki, N., Warming, S., Lamkanfi, M., Vande Walle, L., Louie, S., Dong, J., et al. Non-canonical inflammasome activation targets caspase-11. Nature 479 (2011), 117–121.
94. [94] Shi, J., Zhao, Y., Wang, Y., Gao, W., Ding, J., Li, P., et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 514 (2014), 187–192.
95. [95] Zhao, Y., Yang, J., Shi, J., Gong, Y.-N., Lu, Q., Xu, H., et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477 (2011), 596–600.
96. [96] Kofoed, E.M., Vance, R.E., Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 477 (2011), 592–595.
97. [97] Latz, E., Xiao, T.S., Stutz, A., Activation and regulation of the inflammasomes. Nat Rev Immunol 13 (2013), 397–411.
98. [98] Kayagaki, N., Stowe, I.B., Lee, B.L., O'Rourke, K., Anderson, K., Warming, S., et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526 (2015), 666–671.
99. [99] Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526 (2015), 660–665.
100. [100] Brodsky, I.E., Palm, N.W., Sadanand, S., Ryndak, M.B., Sutterwala, F.S., Flavell, R.A., et al. A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. Cell Host Microbe 7 (2010), 376–387.
101. [101] Chung, L.K., Park, Y.H., Zheng, Y., Brodsky, I.E., Hearing, P., Kastner, D.L., et al. The Yersinia virulence factor YopM hijacks host kinases to inhibit type III effector-triggered activation of the pyrin inflammasome. Cell Host Microbe 20 (2016), 296–306.
102. [102] Johnston, J.B., Barrett, J.W., Nazarian, S.H., Goodwin, M., Ricciuto, D., Ricuttio, D., et al. A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection. Immunity 23 (2005), 587–598.
103. [103] Dorfleutner, A., Talbott, S.J., Bryan, N.B., Funya, K.N., Rellick, S.L., Reed, J.C., et al. A Shope Fibroma virus PYRIN-only protein modulates the host immune response. Virus Genes 35 (2007), 685–694.
104. [104] Komune, N., Ichinohe, T., Ito, M., Yanagi, Y., Measles virus V protein inhibits NLRP3 inflammasome-mediated interleukin-1β secretion. J Virol 85 (2011), 13019–13026.